Both in Biotechnology
Sutro Biopharma vs Lexeo Therapeutics
Over the past year STRO returned +84.0% and LXEO returned −48.6%; their daily moves had a correlation of 0.29.
STRO +84.0% LXEO −48.6%Growth of $1, one year, split-adjusted
| Metric | STRO | LXEO |
|---|---|---|
| Price | $16.10 | $3.42 |
| Market cap | $267.0M | $280.7M |
| Today | +0.44% | +8.92% |
| 1 month | −21.3% | −29.6% |
| 6 months | −33.2% | −35.1% |
| Year to date | +39.2% | −65.6% |
| 1 year | +81.6% | −49.5% |
| Revenue growth (YoY) | −84.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −391.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.8× | — |
| Net cash | $164.3M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 63.4% |
| Short % of float | 13.8% | 28.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).